InvestorsHub Logo
Followers 69
Posts 12025
Boards Moderated 0
Alias Born 08/01/2009

Re: None

Monday, 01/24/2011 11:06:06 AM

Monday, January 24, 2011 11:06:06 AM

Post# of 485
CHBT provides preliminary FY'11 Third Quarter Revenue: the $32 to 33MM rev guidance agrees well with Nevader's estimate of 32.4MM rev for Q3'11. If you look at his article below, he estimated also a Net Inc of 12.96MM and an eps of $.55 for Q3. For FY2011 ending March 2011, his estimates are 118.6MM rev, 43.7MM net inc and $1.87 eps.

Looks like no new bulk customer was added in Dec as the total of 51 is the same as what they reported through Nov'10. I found it interesting that they mentioned in the PR:

Encouraged by the government, both the academia and corporations have been increasing their efforts in expanding the application of probiotics as well as its potential as a replacement for anti-biotics in China. China-Biotics continues to invest in R&D and has increased exchanges with multinational probiotics producers. The company has scheduled to report its fiscal year 2011 third quarter results on Feb 9, 2011.


http://finance.yahoo.com/news/ChinaBiotics-Inc-Provides-prnews-906899398.html?x=0&.v=1

http://seekingalpha.com/article/242696-china-biotics-my-top-stock-pick-for-2011